Stephen John Kiel

Mr. Kiel is the Chief Financial Officer of Ambio Pharmaceuticals, the parent company of AmbioPharm and Ambio. He was previously a Partner at Deloitte Consulting, one of the nation’s Big Four accounting firms. He holds an MBA from The Ohio State University and was awarded a CPA (now inactive) and Series 7 license.

Mr. Kiel is responsible for the financial health of the organization, including financial reporting, cash management, banking and investor relations, and as a government liaison.